Korean Circulation Journal

  • 제48권10호
  • /
  • Pages.930-932
  • /
  • 2018
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Soluble ST2 in Paroxysmal Atrial Fibrillation: a New Biomarker that Predicts Recurrence?

  • AlTurki, Ahmed (Division of Cardiology, McGill University Health Center)
  • 투고 : 2018.06.02
  • 심사 : 2018.06.18
  • 발행 : 2018.10.31
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. AlTurki A, Marshall HJ, Proietti R. Targeting nonpulmonary vein triggers during atrial fibrillation ablation: is the game worth the candle? Curr Opin Cardiol 2018;33:50-7. https://doi.org/10.1097/HCO.0000000000000469
  2. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2017;14:e275-444. https://doi.org/10.1016/j.hrthm.2017.05.012
  3. Balk EM, Garlitski AC, Alsheikh-Ali AA, Terasawa T, Chung M, Ip S. Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review. J Cardiovasc Electrophysiol 2010;21:1208-16. https://doi.org/10.1111/j.1540-8167.2010.01798.x
  4. Tang RB, Yan XL, Dong JZ, et al. Predictors of recurrence after a repeat ablation procedure for paroxysmal atrial fibrillation: role of left atrial enlargement. Europace 2014;16:1569-74. https://doi.org/10.1093/europace/euu013
  5. AbouEzzeddine OF, McKie PM, Dunlay SM, et al. Suppression of tumorigenicity 2 in heart failure with preserved ejection fraction. J Am Heart Assoc 2017;6:e004382.
  6. Aimo A, Vergaro G, Passino C, et al. Prognostic value of soluble suppression of tumorigenicity-2 in chronic heart failure: a meta-analysis. JACC Heart Fail 2017;5:280-6. https://doi.org/10.1016/j.jchf.2016.09.010
  7. Aimo A, Vergaro G, Ripoli A, et al. Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure. JACC Heart Fail 2017;5:287-96. https://doi.org/10.1016/j.jchf.2016.12.016
  8. Eggers KM, Armstrong PW, Califf RM, et al. ST2 and mortality in non-ST-segment elevation acute coronary syndrome. Am Heart J 2010;159:788-94. https://doi.org/10.1016/j.ahj.2010.02.022
  9. Okar S, Kaypakli O, Sahin DY, Koc M. Fibrosis marker soluble ST2 predicts atrial fibrillation recurrence after cryoballoon catheter ablation of nonvalvular paroxysmal atrial fibrillation. Korean Circ J 2018;48:920-9. https://doi.org/10.4070/kcj.2018.0047

피인용 문헌

  1. Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response vol.5, pp.5, 2018, https://doi.org/10.1080/23808993.2020.1804864
  2. Role of sST2 in predicting recurrence of atrial fibrillation after radiofrequency catheter ablation vol.43, pp.11, 2018, https://doi.org/10.1111/pace.14029